Characteristic | Total Cohort | IMPACT Low-Risk | IMPACT High-Risk |
---|---|---|---|
N = 47,531 | N = 9,259 | N = 38,272 | |
n (%) | n (%) | n (%) | |
Age, years (mean ± SD) | 67.1 ± 15.0 | 46.6 ± 11.1 | 72.1 ± 11.0 |
Myocardial infarction | 1,647 (3.5) | 14 (0.2) | 1,633 (4.3) |
Chronic lung disease | 16,242 (34.2) | 636 (6.9) | 15,606 (40.8) |
Stroke | 2,177 (4.6) | 15 (0.2) | 2,162 (5.6) |
Prior major bleeding | 6,233 (13.1) | 101 (1.1) | 6,132 (16.0) |
Atrial fibrillation | 7,810 (16.4) | 51 (0.6) | 7,759 (20.3) |
Cognitive dysfunction | 6,489 (13.7) | 3 (<0.1) | 6,486 (16.9) |
Heart failure | 10,967 (23.1) | 50 (0.5) | 10,917 (28.5) |
Renal failure | 6,941 (14.6) | 60 (0.7) | 6,881 (18.0) |
Liver disease | 1,443 (3.0) | 38 (0.4) | 1,405 (3.7) |
Coagulopathy | 2,828 (6.0) | 75 (0.8) | 2,753 (7.2) |
Cancer | 7,287 (15.3) | 4 (<0.1) | 7,283 (19.0) |